Skip to main content

Table 4 Baseline factors associated with successful treatment outcome (VS/IS)

From: Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study

Baseline characteristic Unadjusted OR (95% CI) Adjusted OR (95% CI)†
Age
> 18 months (vs < 18 mths) 		1.07 (0.39 - 2.96) 4.6 (1.14 -19.1)*
Sex
Male (vs Female) 		0.91 (0.44 - 1.91) 0.71 (0.27 - 1.85)
CD4 cell %
>10% (vs ≤ 10%) 		7.04 (3.07 - 16.19)** 6.97 (2.6 - 18.6)**
HIV-1 RNA (copies/ml)
< 750,000 (vs ≥ 750,000) 		1.95 (0.51 - 7.51) 1.42 (0.29 - 6.98)
WHO stage
1&2 (vs 3) 		2.21 (0.93 - 5.24) 3.50 (1.05 - 12.7)*
WAZ
≤ -2 (vs ≥ -2) 		0.48 (0.20 -1.13) 0.50 (0.14 -1.78)
HAZ
≤ -2 (vs > -2) 		0.79 (0.38 - 1.66) 1.19 (0.39 - 3.65)
  1. †Adjusted for age, sex, CD4 cell %, viral load, WHO stage, WAZ and HAZ. **p < 0.0001 *p = < 0.05. HAZ = Height for age z score, WAZ = weight for age z score and WHO = World Health Organization.
Back to article page